Eli Lilly Posts Better-than-Expected Earnings for Q3 (Reuters)
Drug maker Eli Lilly and Co. reported better-than-expected third-quarter earnings today. The Indianapolis, Ind.-based Lilly earned $1.2 billion ($1.11 per share) in Q3, compared to $1.33 billion ($1.18 per share) in the previous year, beating analysts’ expectations slightly. Lilly’s shares closed the day at $50.15, up from the previous day’s close of $49.65. Earnings were powered by growth in the company’s drugs for depression, diabetes and cancer, in addition to cost-cutting measures. Lilly investors should expect to see similar returns in Q4.
let's see which category it takes... It takes Stock Investor that is the new Uncategorized
This content is for paid subscribers only. To gain access subscribe to one of our…
It is hard to find a seasoned investor who doesn’t believe the stock market is…
No one believes a financial disaster can strike… until it’s too late. That’s bizarre, considering…
The Options Industry Council is a resource used to educate investors about the benefits and…